维敏四联治疗Hp相关的消化性溃疡  

Quadruple therapy with weimin for Hp-positive peptic ulcer

在线阅读下载全文

作  者:钟敏[1] 曾少敏[1] 曾怀端[1] 

机构地区:[1]汕头大学医学院第一附属医院消化内科,广东省汕头市515041

出  处:《世界华人消化杂志》1998年第S2期156-157,共2页World Chinese Journal of Digestology

摘  要:目的应用维敏胶囊(胶态果胶铋)四联药物疗法治疗Hp相关的消化性溃疡(PU)2wk,停药4wk后经内镜、14C-UBT等方法观察溃疡的愈合及Hp根除的疗效方法经内镜确诊为PU,其中十二指肠溃疡(DU)169例;胃溃疡(GU)89例.受检前2wk内未服抗生素、铋剂及质子泵阻断剂,排除孕妇和溃疡出血者,并镜下活检病理排除恶性溃疡Hp检测:先行快速尿素酶检测(RUT),阳性者再行14C-UBT检测,其中DU的Hp阳性率为95.5%;GU的Hp阳性率为81.0%.四联治疗方法:对Hp阳性PU,给予维敏胶囊100mg,4次/d;兰索拉唑30mg,2次/d;阿莫西林0.5g,4次/d;甲硝唑0.4g,2次/d,疗程为2wk.停药后4wk,同时复查内镜及14G-UBT.结果DU愈合率91.2%,Hp根除率93.0%;GU愈合率86.0%,Hp根除率92.0%.DU和GU愈合率及Hp根除率差异不明显(P>0.05);四联疗法后肝肾功能无异常结论Hp与PU关系密切.采用四联治疗Hp相关的PU,有良好效果.14GUBT检测Hp感染具有很高的敏感性和特异性,无创伤性。AIM To study the effect of quedruple therapy with weimin in treatret Of Hp+ peptic ulcer.METHODS Gastroscopically confirmed peptic ulcer patients (DU, duodenal ulcer 169; GU, gastric ulcer 89,maligunt GU was depteted by pethological examination)were tested with Hp (first with RUT, if positive with 14C-UBT). The positive rate of Hp in DU was 95.5%; in GU 81.0%. The treatment methods: weimin 100mg, four times a day; lansoprazole 30 mg, twice a day; amoxycillin 0.5g, four times a day; metronidazole 0.4 g, twice a day,for 2 weeks. Then 4 weeks later all patients were examineted with gastroscope and 14CUBT.RESULTS Curative rate of DU was 91.2% and GU 86.0%, Hp eradication rate in DU was 93.0% and in GU 92.0%, without significent difference statistically (P>0 .05) between DU and GU. Liver and renal functions were normal after treatment.CONCLUSION We has a close relation with peptic ulcer.The quadruple treatment with weimin-lansoprazoleamoxycillin-metronidazole for peptic ulcer is significantly effective. Meantime the 14C-UBT examination for peptic ulcer with Hp is very sensitive and specific.

关 键 词:消化性溃疡/药物疗法 螺杆菌感染/药物疗法 维敏胶囊 胃镜检查 

分 类 号:R573.1[医药卫生—消化系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象